Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: To investigate whether iris blood flow and iris thickness at the iris smooth muscle region affect the pupil diameter at rest and after drug-induced mydriasis in patients with type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM).
Methods: T1DM patients and healthy children were recruited from the SCADE cohort. T2DM patients and healthy adults were recruited from patients undergoing cataract surgery at Shanghai General Hospital. Iris vessel density, pupil diameter (PD) and iris thickness were measured in both the resting and drug-induced mydriasis states. Iris vessel density was measured by optical coherence tomography angiography (OCTA), PD was measured by a pupilometer, and iris thickness at the iris smooth muscle regions were measured using anterior segment optical coherence tomography (AS-OCT).
Results: The study included 34 pediatric T1DM patients and 50 adult T2DM patients, both groups without diabetic retinopathy, and age-sex-matched healthy controls. At baseline, T1DM children and healthy children showed no differences in iris blood flow, iris thickness, or PD. However, the adult T2DM group exhibited higher vessel density at the pupil margin, thinner iris thickness at the iris dilator region, and smaller PD compared to healthy adults, with these differences being statistically significant (P < 0.05). After pupil dilation, there were no changes in iris blood flow and PD in the T1DM group compared to healthy children, whereas the T2DM group showed a significantly smaller PD compared to healthy adults. Multivariate regression analysis revealed that in the T2DM group, glycated hemoglobin was an independent factor of PD after dilation (β=-0.490, p = 0.031), with no such factors identified in the T1DM group.
Conclusion: The insufficiently dilated pupil diameter after drug-induced mydriasis is correlated to the level of glycated hemoglobin among T2DM patients.
Trial Registration: The registration number on the clinical trial website was NCT03631108.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10835944 | PMC |
| http://dx.doi.org/10.1186/s12886-024-03322-y | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Ophthalmic Changes in the Offspring of Pregnant Women with Gestational Diabetes Mellitus or Diabetes Mellitus - A Systematic Review.
Clin Ophthalmol
August 2025
Department of Ophthalmology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, People's Republic of China.
Background: Gestational diabetes mellitus (GDM) affects 5.8% to 25.1% of pregnant women and is associated with a range of adverse perinatal outcomes, including intrauterine growth restriction, prematurity, neonatal respiratory distress, and adiposity.
View Article and Find Full Text PDFLong-Term Outcomes of Iris-Fixated Phakic Intraocular Lenses in Low Myopia: A Retrospective Analysis with Over a Decade of Follow-Up.
Am J Ophthalmol
August 2025
Instituto de Microcirugía Ocular (IMO), Miranza, Barcelona, Spain.
Purpose: To evaluate the clinical indications and long-term outcomes-specifically efficacy, safety, predictability, and stability-of iris-fixated anterior chamber phakic intraocular lenses (pIOLs) in patients with low myopia spherical equivalent (SE) < -6.00 diopters (D).
Design: Retrospective, single-center case series.
Use of a Kerato-lenticule extraction (KLEx) lenticule to protect the lens during pupilloplasty: a novel technique in phakic eyes.
Am J Ophthalmol Case Rep
September 2025
Purpose: Pupilloplasty techniques are delicate, especially in phakic patients where the risk of touching the lens with the needle during the procedure is high. We report the case of a phakic patient in whom we used an allogeneic Kerato-lenticule Extraction (KLEx) lenticule temporarily to protect the lens during the procedure.
Observation: This is a 43-year-old male patient with a significant post-traumatic temporal iris defect.
Are dexamethasone implants a safe and effective breakthrough in uveitis treatment? A systematic review and meta-analysis.
Steroids
August 2025
Department of Ophthalmology, Cardinal Tien Hospital, New Taipei City, Taiwan; School of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan. Electronic address:
Background: Uveitis encompasses inflammatory conditions affecting the iris, ciliary body, and choroid. Its management relied on corticosteroids, immunosuppressive agents, and, more recently, biologic therapies. The development of sustained-release intravitreal corticosteroid delivery systems, like dexamethasone intravitreal implants, has revolutionized the treatment of posterior uveitis.
View Article and Find Full Text PDFClinical characteristics and risk factors of ocular hypertension: a case-control study.
BMC Ophthalmol
August 2025
Department of Ophthalmology, Army Medical Center, Army Medical Univerity, Chongqing, 40042, China.
Purpose: This study investigates the clinical characteristics of ocular hypertension (OHT) by analyzing factors such as Schlemm's canal morphology, intraocular pressure (IOP), iris traits, angle configuration, lens thickness (LT), and retinal nerve fiber layer (RNFL) thickness.
Methods: A total of 60 OHT patients (120 eyes) and 60 healthy controls (120 eyes) underwent cross-sectional and case-control analyses using measurements like IOP, visual acuity, and anterior segment OCT imaging. Statistical analyses involved independent t-tests, Mann-Whitney U tests, correlation analysis, and multivariate logistic regression, with continuous adjustment for spherical equivalent (SE) and central corneal thickness (CCT).